📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy. (2024)

First Author: Dihoum A

Attributed to: Precision medicine for diabetic Individuals: a joint Malaysia-UK Effort (PRIME) project funded by Newton Fund

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12872-024-04022-7

PubMed Identifier: 38997620

Publication URI: http://europepmc.org/abstract/MED/38997620

Type: Journal Article/Review

Volume: 24

Parent Publication: BMC cardiovascular disorders

Issue: 1

ISSN: 1471-2261